Results 81 to 90 of about 1,379 (132)
Candida auris in a tertiary healthcare setting in south India: A case series [PDF]
Candida species can produce a variety of clinical manifestations, and several non-albicans species of Candida, including Candida auris, have been linked to the rise of invasive fungal infections with high rates of treatment failure.
Asem Ashraf, Rohan Pinto, Vimal Karnaker
doaj +1 more source
Standardisation of a Semi-nested PCR for Early Identification of Candida auris: A Cross-sectional Study from Southern India [PDF]
Introduction: Candida auris has drawn more clinical attention due to its multidrug resistance. More than 90% of C. auris isolates are known to be resistant to all the antifungal drugs. Conventionally, the identification of C. auris has not been described
K Vichitra +3 more
doaj +1 more source
The Role of Drug Resistance in Candida Inflammation and Fitness
Drug resistance in Candida may result in either a fitness cost or a fitness advantage. Candida auris, whose intrinsic drug resistance remains unclear, has emerged as a significant human pathogen. We aimed to investigate whether Candida fitness, including
Gabriella Piatti +4 more
doaj +1 more source
Candida auris in Dutch hospitals: are we ready for it?
Candida auris can cause nosocomial outbreaks and provides challenges concerning diagnosis, treatment, eradication and infection prevention. There are no Dutch standards or guidelines for C. auris, and current hospital practices are unknown. Therefore, we assessed whether Dutch hospitals are prepared for C.
Dix, L M L +3 more
openaire +6 more sources
Biocide Response of Candida auris
ABSTRACT Candida auris is an emerging multidrug‐resistant yeast demonstrating remarkable persistence in healthcare environments, contributing to nosocomial transmission and outbreak persistence.
Sidre Erganis +3 more
openaire +1 more source
FIRST CASES IN BULGARIA WITH PROVEN CANDIDA AURIS IN IMMUNOCOMPROMISED PATIENTS
Candida auris is a fungus with pathogenic potential, first isolated in 2009 in Japan. Since then, sporadic cases have been reported, which have increased significantly in recent years.
Lyubomira Boyanova +2 more
doaj +1 more source
mGem: Fungal adhesins in Candidozyma auris confer unique fitness for skin colonization
Candidozyma auris (formerly Candida auris) is an emerging multidrug-resistant fungal pathogen that causes life-threatening infections in humans. C. auris is distinct from other Candida species and exhibits exceptional capacity for skin colonization ...
Abishek Balakumar, Shankar Thangamani
doaj +1 more source
Background: This study evaluated the utility of fluconazole disk diffusion on CHROMagar Candida Plus for differentiating Candidozyma auris from Candida parapsilosis. Methods: In this in vitro study, clinical isolates of both C. auris and C.
Sarah Israel +8 more
doaj +1 more source
Recurrent Fungemia Due to Candida auris
We present a case of recurrent multidrug-resistant Candida auris (C. auris) in a patient who required multiple hospitalizations. The patient's case was complicated by interval admissions to the intensive care unit for septic and hypovolemic shock for 12 months to manage C. auris fungemia.
Griffith, Emma M +4 more
openaire +2 more sources
In this study, we investigated the interactions between Candida auris and C. albicans, C. tropicalis, C. glabrata, and C. krusei in mixed infections. Initially, these interactions were studied qualitatively and quantitatively in dual-species biofilms ...
Monika Janeczko, Tomasz Skrzypek
doaj +1 more source

